is typically collected before bringing a vaccine to market. No surprise then that regulators chose to err on the side of caution. For members of the public who are hesitant to take a vaccine, Tuesday’s action should boost confidence, not erode it.
It is possible that the regulators will allow J&J shots to resume in short order. But if not, the U.S. government has diversified its vaccine options, a decision that is looking increasingly prescient. As such, there is plenty of supply even if the J&J vaccine is mothballed over the long term.
There will be new challenges if the J&J vaccine doesn’t rejoin the mix. It requires only one dose, while Pfizer and Moderna each require two. If the J&J shot is no longer an option, the government will need to rethink how to supply rural and other hard-to-reach communities with vaccines.
heard Women that have not enter in their Menopause cycle should take into consideration the J&J or Astrazeneca vacine. Why you may ask, that´s CDC job to find out, but it has something to do with hormones. But for Men, If you want to continued, go ahead. Tell J&J, CDC,FDA they own me!
heard
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.